Follow
Leif Erik Sander, MD
Leif Erik Sander, MD
Department of Infectious Diseases & Respiratory Medicine Charité - Universitätsmedizin Berlin
Verified email at charite.de - Homepage
Title
Cited by
Cited by
Year
Severe COVID-19 is marked by a dysregulated myeloid cell compartment
J Schulte-Schrepping, N Reusch, D Paclik, K Baßler, S Schlickeiser, ...
Cell 182 (6), 1419-1440. e23, 2020
12492020
SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19
J Braun, L Loyal, M Frentsch, D Wendisch, P Georg, F Kurth, ...
Nature 587 (7833), 270-274, 2020
12032020
COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis
RL Chua, S Lukassen, S Trump, BP Hennig, D Wendisch, F Pott, ...
Nature biotechnology 38 (8), 970-979, 2020
9862020
Mapping the human genetic architecture of COVID-19
Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ...
Nature 600 (7889), 472-477, 2021
7002021
Swarm learning for decentralized and confidential clinical machine learning
S Warnat-Herresthal, H Schultze, KL Shastry, S Manamohan, ...
Nature 594 (7862), 265-270, 2021
5342021
Estimating infectiousness throughout SARS-CoV-2 infection course
TC Jones, G Biele, B Mühlemann, T Veith, J Schneider, ...
Science 373 (6551), eabi5273, 2021
4842021
Detection of prokaryotic mRNA signifies microbial viability and promotes immunity
LE Sander, MJ Davis, MV Boekschoten, D Amsen, CC Dascher, B Ryffel, ...
Nature 474 (7351), 385-389, 2011
4722011
Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection
CB Messner, V Demichev, D Wendisch, L Michalick, M White, A Freiwald, ...
Cell systems 11 (1), 11-24. e4, 2020
4612020
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant
H Gruell, K Vanshylla, P Tober-Lau, D Hillus, P Schommers, C Lehmann, ...
Nature medicine 28 (3), 477-480, 2022
4032022
Lymphocyte circadian clocks control lymph node trafficking and adaptive immune responses
D Druzd, O Matveeva, L Ince, U Harrison, W He, C Schmal, H Herzel, ...
Immunity 46 (1), 120-132, 2017
3992017
Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function
LE Sander, SD Sackett, U Dierssen, N Beraza, RP Linke, M Müller, ...
Journal of Experimental Medicine 207 (7), 1453-1464, 2010
3782010
Human anti-fungal Th17 immunity and pathology rely on cross-reactivity against Candida albicans
P Bacher, T Hohnstein, E Beerbaum, M Röcker, MG Blango, S Kaufmann, ...
Cell 176 (6), 1340-1355. e15, 2019
3612019
Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study
D Hillus, T Schwarz, P Tober-Lau, K Vanshylla, H Hastor, C Thibeault, ...
The Lancet Respiratory Medicine 9 (11), 1255-1265, 2021
3452021
Beyond pattern recognition: five immune checkpoints for scaling the microbial threat
JM Blander, LE Sander
Nature Reviews Immunology 12 (3), 215-225, 2012
3312012
A therapeutic non-self-reactive SARS-CoV-2 antibody protects from lung pathology in a COVID-19 hamster model
J Kreye, SM Reincke, HC Kornau, E Sánchez-Sendin, VM Corman, H Liu, ...
Cell 183 (4), 1058-1069. e19, 2020
3232020
SARS-CoV-2 infection triggers profibrotic macrophage responses and lung fibrosis
D Wendisch, O Dietrich, T Mari, S von Stillfried, IL Ibarra, M Mittermaier, ...
Cell 184 (26), 6243-6261. e27, 2021
3052021
Longitudinal multi-omics analyses identify responses of megakaryocytes, erythroid cells, and plasmablasts as hallmarks of severe COVID-19
JP Bernardes, N Mishra, F Tran, T Bahmer, L Best, JI Blase, D Bordoni, ...
Immunity 53 (6), 1296-1314. e9, 2020
2952020
Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense
J Garaude, R Acín-Pérez, S Martínez-Cano, M Enamorado, M Ugolini, ...
Nature immunology 17 (9), 1037-1045, 2016
2832016
Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children
J Loske, J Röhmel, S Lukassen, S Stricker, VG Magalhães, J Liebig, ...
Nature biotechnology 40 (3), 319-324, 2022
2722022
IFNs Modify the Proteome of Legionella-Containing Vacuoles and Restrict Infection Via IRG1-Derived Itaconic Acid
J Naujoks, C Tabeling, BD Dill, C Hoffmann, AS Brown, M Kunze, ...
PLoS pathogens 12 (2), e1005408, 2016
2412016
The system can't perform the operation now. Try again later.
Articles 1–20